EU competition authorities to rule on Novo’s purchase of Catalent by 6 December

EU competition authorities will decide by 6 December whether to approve Novo Holdings’ acquisition of contract drugmaker Catalent, the European Commission said in a document published on its website on Monday.

Teile diesen Beitrag: